Pixee Medical was granted FDA 510(k) clearance for Knee+ NexSight, developed on a new augmented reality (AR) platform for total knee arthroplasty.
This new clearance enables Pixee Medical to focus on ambulatory surgical centers (ASCs), where efficiency, simplicity, and cost control are key drivers. Deployed on a new, more compact AR platform, it enhances surgeon comfort, improves overall efficiency, and increases adaptability in the operating room, while ensuring full compatibility with the surgical hood.
The system includes a discreet virtual display directly in the surgeon’s field of view, along with voice control, enabling a fully hands-free and intuitive surgical experience. With no disposable components, the system also offers clear economic and environmental benefits.
Knee+ NexSight is fully compatible with most primary knee implants and personalized surgical approaches, including kinematic alignment.
Knee+ NexSight received CE Mark approval in February 2026, with initial cases successfully performed in Europe.
Pixee Medical was granted FDA 510(k) clearance for Knee+ NexSight, developed on a new augmented reality (AR) platform for total knee arthroplasty.
This new clearance enables Pixee Medical to focus on ambulatory surgical centers (ASCs), where efficiency, simplicity, and cost control are key drivers. Deployed on a new, more compact AR platform,...
Pixee Medical was granted FDA 510(k) clearance for Knee+ NexSight, developed on a new augmented reality (AR) platform for total knee arthroplasty.
This new clearance enables Pixee Medical to focus on ambulatory surgical centers (ASCs), where efficiency, simplicity, and cost control are key drivers. Deployed on a new, more compact AR platform, it enhances surgeon comfort, improves overall efficiency, and increases adaptability in the operating room, while ensuring full compatibility with the surgical hood.
The system includes a discreet virtual display directly in the surgeon’s field of view, along with voice control, enabling a fully hands-free and intuitive surgical experience. With no disposable components, the system also offers clear economic and environmental benefits.
Knee+ NexSight is fully compatible with most primary knee implants and personalized surgical approaches, including kinematic alignment.
Knee+ NexSight received CE Mark approval in February 2026, with initial cases successfully performed in Europe.
Copy to clipboard 
